BackIVERIC bio Overview

IVERIC bio Current Assets

Track IVERIC bio's current assets ($610M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$611.54M
74.25% YoYΔ $260.58M vs prior year quarter

Peer average

Loading

IVERIC bio Current Assets History

Loading

IVERIC bio vs. peers: Current Assets Comparison

Loading

IVERIC bio Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

IVERIC bio (ISEE) FAQ

As of the most recent data (March 2023), ISEE shows a current assets of $610M. That compares with $350M in the prior-year period — up 74.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ISEE's current assets is now $610M (was $350M) — a 74.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether IVERIC bio is outperforming or lagging.

Tracking ISEE's current assets over time shows whether IVERIC bio is scaling, shrinking, or reshaping that part of the business. The current reading is $610M That compares with $350M in the prior-year period — up 74.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has IVERIC bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $610M) with ownership activity and broader fundamentals.

IVERIC bio's current assets is $610M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.